TR
EN
Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients
Öz
In this study, our aim was to determine the anxiety levels of patients diagnosed with DTC and to investigate the relationships between anxiety and factors such as age, sex, marital status, the presence of metastasis, time since diagnosis, whether they received RIT, and the dose of radioactive iodine they received.
This prospective study was conducted between January 2024 and June 2024. Clinical findings and demographic data of 164 patients who applied to the nuclear medicine outpatient clinic were recorded, and anxiety levels were measured via the Beck Anxiety Inventory. Statistical analyses were performed via SPSS 23.0. The statistical significance level was accepted as p<0.05.
When the gender of the patients was compared with the Beck anxiety level, a statistically significant relationship was found (p=0.007). No significant relationship was found between the marital status, the presence of metastasis, the status of receiving radioactive iodine treatment or histopathological subtype and the Beck anxiety level.
Anxiety levels in patients with differentiated thyroid cancer were found to be significantly higher in females than in males.
Anahtar Kelimeler
Etik Beyan
Before starting the study, ethical approval was obtained from the Pamukkale University Non-Interventional Clinical Research Ethics Committee (dated 26.12.2023 and numbered 21).
Teşekkür
We would like to thank Miyase Nur ATALAY, Mert CENGİZ and Yavuz ÖZLÜ for their data entry of patient information.
Kaynakça
- 1. Lepore SJ, Coyne JC. Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med. 2006;32(2):85- 92.
- 2. Sloan PA, LaFountain P, Plymale M, Johnson M, Snapp J, Sloan DA. Cancer pain education for medical students: the development of a short course on CD-ROM. Pain Med. 2002;3(1):66-72.
- 3. Tokgöz G, Yalu İ, Özdemir S, Yazıcı A, Uygun K, Aker T. Kanser hastalarında majör depresyon yaygınlığı ve ilişkili etkenler. Anadolu Psikiyatri Dergisi 2008;9:59-66.
- 4. Berard RM. Depression and anxiety in oncology: the psychiatrist's perspective. J Clin Psychiatry. 2001;62 Suppl 8:58-61; discussion 62- 3.
- 5. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63.
- 6. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
- 7. Brito JP, Ito Y, Miyauchi A, Tuttle RM. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. Thyroid. 2016;26(1):144-9.
- 8. Albalawi IA, Mirghani HO. Lobectomy versus total thyroidectomy in differentiated thyroid carcinoma: A review. AMJ 2019;12(10):285– 91.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Nükleer Tıp
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
15 Eylül 2025
Gönderilme Tarihi
14 Ocak 2025
Kabul Tarihi
12 Mayıs 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 15 Sayı: 3
APA
Gültekin, A., & Şengöz, T. (2025). Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi, 15(3), 255-262. https://doi.org/10.16919/bozoktip.1619616
AMA
1.Gültekin A, Şengöz T. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 2025;15(3):255-262. doi:10.16919/bozoktip.1619616
Chicago
Gültekin, Aziz, ve Tarık Şengöz. 2025. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi 15 (3): 255-62. https://doi.org/10.16919/bozoktip.1619616.
EndNote
Gültekin A, Şengöz T (01 Eylül 2025) Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi 15 3 255–262.
IEEE
[1]A. Gültekin ve T. Şengöz, “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”, Bozok Tıp Dergisi, c. 15, sy 3, ss. 255–262, Eyl. 2025, doi: 10.16919/bozoktip.1619616.
ISNAD
Gültekin, Aziz - Şengöz, Tarık. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi 15/3 (01 Eylül 2025): 255-262. https://doi.org/10.16919/bozoktip.1619616.
JAMA
1.Gültekin A, Şengöz T. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 2025;15:255–262.
MLA
Gültekin, Aziz, ve Tarık Şengöz. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi, c. 15, sy 3, Eylül 2025, ss. 255-62, doi:10.16919/bozoktip.1619616.
Vancouver
1.Aziz Gültekin, Tarık Şengöz. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 01 Eylül 2025;15(3):255-62. doi:10.16919/bozoktip.1619616